Peng Xu

4.1k total citations · 2 hit papers
117 papers, 2.0k citations indexed

About

Peng Xu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Peng Xu has authored 117 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 25 papers in Oncology and 18 papers in Surgery. Recurrent topics in Peng Xu's work include CRISPR and Genetic Engineering (8 papers), RNA modifications and cancer (8 papers) and CAR-T cell therapy research (8 papers). Peng Xu is often cited by papers focused on CRISPR and Genetic Engineering (8 papers), RNA modifications and cancer (8 papers) and CAR-T cell therapy research (8 papers). Peng Xu collaborates with scholars based in China, United States and Germany. Peng Xu's co-authors include Elena Sotillo, Robbie G. Majzner, Evan W. Weber, Ansuman T. Satpathy, Rachel C. Lynn, Jeffrey M. Granja, Hima Anbunathan, Victor Tieu, Howard Y. Chang and David Gennert and has published in prestigious journals such as Nature, Nucleic Acids Research and Nature Genetics.

In The Last Decade

Peng Xu

105 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

c-Jun overexpression in CAR T cells induces exhaustion resistance

2019 514 citations Evan W. Weber, Elena Sotillo et al. Nature profile →
Co-opting signalling molecules enables logic-gated control of CAR T cells

2023 170 citations Aidan M. Tousley, Maria Caterina Rotiroti et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peng Xu China	22	899	760	392	281	225	117	2.0k
David Gallego‐Ortega Australia	28	1.1k 1.2×	775 1.0×	426 1.1×	301 1.1×	132 0.6×	56	2.2k
Yasuto Akiyama Japan	27	878 1.0×	937 1.2×	708 1.8×	113 0.4×	148 0.7×	128	2.2k
Christina H. Stuelten United States	24	1.5k 1.7×	880 1.2×	454 1.2×	232 0.8×	235 1.0×	38	3.1k
Carolin Mogler Germany	29	1.1k 1.2×	656 0.9×	397 1.0×	161 0.6×	89 0.4×	126	2.7k
Steffen Rickelt United States	21	675 0.8×	780 1.0×	412 1.1×	183 0.7×	73 0.3×	47	1.7k
Raúl Catena Spain	24	1.3k 1.5×	679 0.9×	445 1.1×	135 0.5×	97 0.4×	30	2.2k
Simona Osella‐Abate Italy	28	810 0.9×	1.1k 1.5×	575 1.5×	143 0.5×	92 0.4×	89	2.4k
Paola Nisticò Italy	28	1.3k 1.4×	1.2k 1.6×	678 1.7×	175 0.6×	99 0.4×	69	2.7k
Elizabeth S. Nakasone United States	8	716 0.8×	878 1.2×	908 2.3×	376 1.3×	105 0.5×	15	2.1k
Aibin Liang China	19	689 0.8×	498 0.7×	202 0.5×	131 0.5×	115 0.5×	117	1.5k

Countries citing papers authored by Peng Xu

Since Specialization

Citations

This map shows the geographic impact of Peng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Xu more than expected).

Fields of papers citing papers by Peng Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Xu. The network helps show where Peng Xu may publish in the future.

Co-authorship network of co-authors of Peng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Xu. A scholar is included among the top collaborators of Peng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Xu. Peng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Cheng, Xin Ye, Jianxiang Zhang, et al.. (2025). CTCF is selectively required for maintaining chromatin accessibility and gene expression in human erythropoiesis. Genome biology. 26(1). 44–44. 2 indexed citations

Xu, Peng, Chengquan Zhao, Xue Li, et al.. (2025). Gene editing tools promote the development of chloroplast gene engineering. Current Plant Biology. 44. 100540–100540.

Xu, Peng, et al.. (2025). Urban road boundary detection method based on 3D LiDAR and road shape classification. Measurement. 256. 118073–118073.

Zhang, Lei, et al.. (2024). A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults. Thrombosis Journal. 22(1). 82–82. 2 indexed citations

Xu, Peng, Yuankui Wu, Chu Han, et al.. (2024). CroMAM: A Cross-Magnification Attention Feature Fusion Model for Predicting Genetic Status and Survival of Gliomas Using Histological Images. IEEE Journal of Biomedical and Health Informatics. 28(12). 7345–7356. 3 indexed citations

Wang, Guangying, Lin Jiang, Shilai Zhang, et al.. (2024). Heterogeneity characterization of psychiatric diseases based on common orthogonal basis extraction. 1–5. 1 indexed citations

Azi, Fidelis, et al.. (2023). Synthetic consortium of Ganoderma lucidum and Lactobacillus plantarum for enhanced natural products biosynthesis. Biochemical Engineering Journal. 196. 108950–108950. 7 indexed citations

Cao, Yue, Peng Xu, Wei Wu, et al.. (2023). Exosomes and cancer immunotherapy: A review of recent cancer research. Frontiers in Oncology. 12. 1118101–1118101. 19 indexed citations

Xu, Peng, Jun Wang, Yaodong Wang, et al.. (2023). LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p/THBS2/PI3K-Akt pathway. Cancer Cell International. 23(1). 330–330. 10 indexed citations

10.

Zhang, Mengli, Shaela Wright, Xiaowen Chen, et al.. (2023). RNA-Binding Protein RBM5 Plays an Essential Role in Acute Myeloid Leukemia By Activating the Oncogenic Protein HOXA9. Blood. 142(Supplement 1). 4130–4130. 1 indexed citations

11.

Song, Meiyu, et al.. (2023). Hsa_circ_0001326 inhibited the proliferation, migration, and invasion of trophoblast cells via miR‐145‐5p/TGFB2 axis. American Journal of Reproductive Immunology. 89(5). e13682–e13682. 5 indexed citations

12.

Tousley, Aidan M., Maria Caterina Rotiroti, Louai Labanieh, et al.. (2023). Co-opting signalling molecules enables logic-gated control of CAR T cells. Nature. 615(7952). 507–516. 170 indexed citations breakdown →

13.

Balke‐Want, Hyatt, Nikolaos Gkitsas, Gavin Kurgan, et al.. (2023). Homology-independent targeted insertion (HITI) enables guided CAR knock-in and efficient clinical scale CAR-T cell manufacturing. Molecular Cancer. 22(1). 100–100. 24 indexed citations

14.

Feng, Ruopeng, Thiyagaraj Mayuranathan, Peng Huang, et al.. (2022). Activation of γ-globin expression by hypoxia-inducible factor 1α. Nature. 610(7933). 783–790. 37 indexed citations

15.

Shrivastav, Shashi, Hewang Lee, Huiyan Lü, et al.. (2022). HIV-1 Vpr suppresses expression of the thiazide-sensitive sodium chloride co-transporter in the distal convoluted tubule. PLoS ONE. 17(9). e0273313–e0273313.

16.

Sherpa, Dawafuti, Judith Mueller, Özge Karayel, et al.. (2022). Modular UBE2H-CTLH E2-E3 complexes regulate erythroid maturation. eLife. 11. 15 indexed citations

17.

Cao, Cong, Xi Yang, Guowei Zhao, et al.. (2022). Nrf2 expands the intracellular pool of the chaperone AHSP in a cellular model of β-thalassemia. Redox Biology. 50. 102239–102239. 15 indexed citations

18.

Zhang, Mengli, Mei Meng, Yuxi Liu, et al.. (2021). Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins. Breast Cancer Research. 23(1). 21 indexed citations

19.

Qi, Qian, Cheng Li, Xing Tang, et al.. (2020). Dynamic CTCF binding directly mediates interactions among cis-regulatory elements essential for hematopoiesis. Blood. 137(10). 1327–1339. 26 indexed citations

20.

Xu, Peng, Lance E. Palmer, Christophe Lechauve, et al.. (2019). Regulation of gene expression by miR-144/451 during mouse erythropoiesis. Blood. 133(23). 2518–2528. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact